SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as a long-standing satirical project that has transitioned onto the Solana network, with the community positioning it as a cultural successor to early Bitcoin lore. Supporters are actively discussing its 15-year history and perceived potential for generational wealth, while debates continue between those dismissing it as a meme-driven joke and those convinced it represents a unique opportunity in the current market cycle.

Amtech Systems, Inc. engages in the manufacture of semiconductors and capital equipment. It operates through the Semiconductor and Material and Substrate segments. The Semiconductor segment involves the designing, manufacturing, selling, and servicing of thermal processing equipment and related controls for use by semiconductor manufacturers, and in electronics, automotive, and other industries. The Material and Substrate segment produces consumables and machinery for lapping and polishing materials, such as sapphire substrates, optical components, silicon wafers, and numerous types of crystal materials, ceramics, and metal components. The company was founded by Jong S. Whang in October 1981 and is headquartered in Tempe, AZ.

Amtech Systems Inc.

Amtech Systems is gaining momentum as investors eye its strategic role in the AI-driven semiconductor supply chain, specifically through its exposure to advanced packaging and wafer substrate fabrication. While the community remains optimistic about the company's long-term growth potential and turnaround narrative, discussions are increasingly balanced by caution regarding recent earnings performance and sector-wide cyclical risks.

MMTec, Inc. engages in the holding of an equity interest in MM Future. It operates through the Gujia, MM Future and HC Securities and MM Global. The Gujia, MM Future and HC Securities segment provide market data services and consulting services. The MM Global segment is involved in introducing a broker that clears all transactions through a clearing broker dealer and earns commission income, placement agent services fee, and other related income from customers. The company was founded on January 4, 2018 and is headquartered in Hong Kong.

Mmtec Inc

Mmtec Inc is generating significant market interest as traders speculate on potential short squeeze dynamics and the company's efforts to maintain its NASDAQ listing status. Community discussions are heavily focused on the stock's extreme volatility and its tendency to mirror past microcap momentum plays, with participants actively debating the risks of delisting against the possibility of aggressive rallies.

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

YD Bio Ltd.

YDES is currently garnering significant attention from retail traders due to its status as a recent Nasdaq uplisting with a remarkably low float, leading to discussions about potential volatility and short-squeeze setups. The community is closely monitoring the stock's price action alongside its associated warrants, debating whether current valuations present a mispricing opportunity or a speculative trap.

GitLab, Inc. engages in the intelligent development, security, and operations (DevSecOps) platform for software innovation. It enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab ($GTLB) is trending as investors weigh potential buyout interest alongside concerns that AI-driven coding tools may disrupt its long-term growth and market share. Community members are actively debating the stock's valuation as a recovery play, while simultaneously tracking high-volume trading activity and rumors of strategic acquisition interest.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is trending as investors weigh its potential as a key memory interface player against volatility surrounding recent quarterly results, with the community actively debating whether current price levels represent a significant discount or a continued downtrend. Discussions are dominated by the company's long-term integration into AI and data center infrastructure, contrasting sharply with concerns over immediate execution risks and recent management turnover.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as investors express significant frustration and skepticism toward the Board's decision to accept an all-cash acquisition offer, which many feel drastically undervalues the company's cash position, core drug assets, and future growth potential. The community is actively debating the merits of the deal, with some shareholders organizing to oppose the tender offer and others seeking legal avenues to challenge what they characterize as an unethical 'fire sale' by management.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN is trending due to its unique 'PvE' (Player-versus-Environment) narrative, which emphasizes long-term community conviction over short-term speculative trading. Supporters are actively highlighting the project's 'Airlock' mechanismwhere nearly half of the supply is voluntarily lockedas proof of a committed, cult-like movement that is actively outperforming typical market volatility.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

ProShares Ultra Semiconductors is trending as investors capitalize on surging demand for AI infrastructure, with the community actively debating whether to scale into the leveraged ETF or diversify directly into underlying chip giants like Nvidia. Discussions are heavily focused on navigating current market volatility and the structural implications of a shifting macroeconomic environment on semiconductor valuations.

Ethereum Classic

Ethereum Classic is experiencing renewed community focus as investors speculate on a long-awaited breakout, with many sentiment-driven discussions highlighting the contrast between the token's historical performance and its current suppressed price action. Traders are actively debating the timing of a potential trend reversal, frequently citing broader crypto market catalysts and comparing its utility to other established proof-of-work assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving Average - Here's What Happened

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average - Should You Sell...

Maxim Group Reiterates "Buy" Rating for MediciNova (NASDAQ:MNOV)

Maxim Group reaffirmed a "buy" rating and set a $6.00 price objective on shares of MediciNova in a report on Monday...

MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have received a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, two have i...

MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research

Zacks Research raised MediciNova to a "hold" rating in a research note on Tuesday...

Q1 Earnings Estimate for MediciNova Issued By HC Wainwright

MediciNova, Inc. (NASDAQ:MNOV - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for MediciNova in a research report issued on Monday, March 16th...

MediciNova (NASDAQ:MNOV) Now Covered by HC Wainwright

HC Wainwright initiated coverage on shares of MediciNova in a research note on Monday. They issued a "buy" rating and a $10.00 price target on the stock...

MediciNova (NASDAQ:MNOV) Stock Passes Above 200-Day Moving Average - Should You Sell?

MediciNova (NASDAQ:MNOV) Stock Passes Above 200 Day Moving Average - Should You Sell...

Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) have earned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat reports. One...

MediciNova (NASDAQ:MNOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

MediciNova (NASDAQ:MNOV - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.05) EPS for the quarter, beating the consensus estimate of...

MediciNova, Inc. (NASDAQ:MNOV) Short Interest Update

MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) was the target of a large drop in short interest in January. As of January 30th, there was short interest totaling 225,373 shares, a drop of 16.7...

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

MNOV
Medicinova Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNOV News

MNOVMedicinova Inc